echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 100 million US dollars to help develop precision Parkinson's disease treatment The main drug enters clinical development this year

    100 million US dollars to help develop precision Parkinson's disease treatment The main drug enters clinical development this year

    • Last Update: 2022-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Neuron23 announced the completion of a $100 million Series C financing


    LRRK2 is a multi-protein domain complex protein found in neurons and other tissues and cell types throughout the body


    Founded in 2018, Neuron23 is committed to harnessing the latest advances in human genetics, combined with cutting-edge AI-powered drug discovery and biomarker platforms, to develop innovative treatments for serious diseases


    References:

    [1] Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease.


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.